2. Academic Validation
  3. The impact of quercetin and paclitaxel combination on ovarian cancer cells

The impact of quercetin and paclitaxel combination on ovarian cancer cells

  • iScience. 2024 Jul 1;27(8):110434. doi: 10.1016/j.isci.2024.110434.
Huihui Ji 1,  Zihan Zhang 1,  Cheng Chen 1,  Wenbin Xu 1,  Tingxian Liu 1,  Yue Dong 1,  Jiakun Wang 2,  Huihui Wang 1,  Xueqiong Zhu 1 2
Affiliations

Affiliations

  • 1 Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
  • 2 Department of Obstetrics and Gynecology, Taizhou Women and Children's Hospital of Wenzhou Medical University, Zhejiang, China.
PMID: 39108714 DOI: 10.1016/j.isci.2024.110434
Abstract

Ovarian Cancer is a highly lethal gynecological malignancy, emphasizing the need for effective treatment strategies. This study investigated the synergistic effects of quercetin and paclitaxel on ovarian Cancer. Using SKOV3 and A2780 cell lines, we found that the combined treatment significantly enhanced cell Apoptosis and inhibited invasion and migration compared to individual treatments. Then, we identified 32 common targets between quercetin/paclitaxel and ovarian Cancer, with 29 genes showing differential expression between normal ovarian tissue and ovarian tumor tissue. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses revealed that quercetin and paclitaxel modulated cancer-related pathways in ovarian Cancer treatment. Mechanistic analysis further discovered that the synergistic effect was mediated by downregulating ERBB2 and BIRC5 and upregulating CASP3 expression. This study provides strong evidence that quercetin enhances the effectiveness of paclitaxel in treating ovarian Cancer.

Keywords

Cancer; Cell biology; Therapy.

Figures
Products